Shenzhen Neptunus Interlong Bio-Technique Co (HKSE:08329) Beneish M-Score: -3.57 (As of Sep. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:08329 Shenzhen Neptunus Interlong Bio-Technique Co Ltd HKSE:08329
48 GF Score
Price HK$0.10
GF Value HK$0.14
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Shenzhen Neptunus Interlong Bio-Technique Co Beneish M-Score?

Shenzhen Neptunus Interlong Bio-Technique Co HKSE:08329 -5.71% 48 Beneish M-Score is -3.57 as of Sep. 15, 2026. GuruFocus rates HKSE:08329 with a GF Score™ of 48/100 and a GF Value™ of HK$0.14 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 919 Drug Manufacturers companies, Shenzhen Neptunus Interlong Bio-Technique Co ranks better than 93.04% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -3.57 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Shenzhen Neptunus Interlong Bio-Technique Co's Beneish M-Score or its related term are showing as below:

HKSE:08329' s Beneish M-Score Range Over the Past 10 Years
Min: -3.57   Med: -2.42   Max: -1.3
Current: -3.57

During the past 13 years, the highest Beneish M-Score of Shenzhen Neptunus Interlong Bio-Technique Co was -1.30. The lowest was -3.57. And the median was -2.42.


Shenzhen Neptunus Interlong Bio-Technique Co Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Shenzhen Neptunus Interlong Bio-Technique Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shenzhen Neptunus Interlong Bio-Technique Co Beneish M-Score Chart

Shenzhen Neptunus Interlong Bio-Technique Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.48 -2.51 -2.57 -2.10 -3.30

Shenzhen Neptunus Interlong Bio-Technique Co Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.54 -2.10 -2.47 -3.30 -3.01

HKSE:08329 vs ZTS: Beneish M-Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Shenzhen Neptunus Interlong Bio-Technique Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shenzhen Neptunus Interlong Bio-Technique Co Beneish M-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shenzhen Neptunus Interlong Bio-Technique Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Shenzhen Neptunus Interlong Bio-Technique Co's Beneish M-Score falls into.


HKSE:08329
48GF Score
Shenzhen Neptunus Interlong Bio-Technique Co Ltd HKSE:08329
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shenzhen Neptunus Interlong Bio-Technique Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Shenzhen Neptunus Interlong Bio-Technique Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9975+0.528 * 1.0661+0.404 * 0.6058+0.892 * 0.9334+0.115 * 1.0224
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0056+4.679 * -0.165089-0.327 * 1.2596
=-3.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Total Receivables was HK$316 Mil.
Revenue was HK$1,054 Mil.
Gross Profit was HK$309 Mil.
Total Current Assets was HK$727 Mil.
Total Assets was HK$1,177 Mil.
Property, Plant and Equipment(Net PPE) was HK$291 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$36 Mil.
Selling, General, & Admin. Expense(SGA) was HK$266 Mil.
Total Current Liabilities was HK$362 Mil.
Long-Term Debt & Capital Lease Obligation was HK$3 Mil.
Net Income was HK$-44 Mil.
Gross Profit was HK$0 Mil.
Cash Flow from Operations was HK$150 Mil.
Total Receivables was HK$340 Mil.
Revenue was HK$1,129 Mil.
Gross Profit was HK$353 Mil.
Total Current Assets was HK$861 Mil.
Total Assets was HK$1,488 Mil.
Property, Plant and Equipment(Net PPE) was HK$296 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$37 Mil.
Selling, General, & Admin. Expense(SGA) was HK$283 Mil.
Total Current Liabilities was HK$362 Mil.
Long-Term Debt & Capital Lease Obligation was HK$4 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(316.485 / 1054.166) / (339.923 / 1129.434)
=0.300223 / 0.300968
=0.9975

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(352.982 / 1129.434) / (309.035 / 1054.166)
=0.31253 / 0.293156
=1.0661

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (726.733 + 291.478) / 1176.813) / (1 - (860.976 + 295.897) / 1487.86)
=0.134772 / 0.222458
=0.6058

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1054.166 / 1129.434
=0.9334

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(37.476 / (37.476 + 295.897)) / (36.006 / (36.006 + 291.478))
=0.112415 / 0.109948
=1.0224

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(265.948 / 1054.166) / (283.346 / 1129.434)
=0.252283 / 0.250874
=1.0056

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((3.037 + 361.608) / 1176.813) / ((3.74 + 362.282) / 1487.86)
=0.309858 / 0.246006
=1.2596

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-44.182 - 0 - 150.097) / 1176.813
=-0.165089

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Shenzhen Neptunus Interlong Bio-Technique Co has a M-score of -3.52 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -3.57 mean?
Shenzhen Neptunus Interlong Bio-Technique Co (HKSE:08329) has a Beneish M-Score of -3.57 as of Sep. 15, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Shenzhen Neptunus Interlong Bio-Technique Co and its competitors. According to the industry distribution chart, Shenzhen Neptunus Interlong Bio-Technique Co ranks #64 out of 919 companies in the Drug Manufacturers industry, placing it in the top 7%.
Is Shenzhen Neptunus Interlong Bio-Technique Co's Beneish M-Score too high?
Shenzhen Neptunus Interlong Bio-Technique Co's current Beneish M-Score is -3.57. Based on the distribution chart, Shenzhen Neptunus Interlong Bio-Technique Co ranks #64 out of 919 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Shenzhen Neptunus Interlong Bio-Technique Co has a GF Score™ of 48/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shenzhen Neptunus Interlong Bio-Technique Co's Beneish M-Score compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Shenzhen Neptunus Interlong Bio-Technique Co ranks #64 out of 919 companies for Beneish M-Score. This places Shenzhen Neptunus Interlong Bio-Technique Co in the top 7% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Drug Manufacturers company?
A good Beneish M-Score depends on the Drug Manufacturers industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Shenzhen Neptunus Interlong Bio-Technique Co and its competitors. Shenzhen Neptunus Interlong Bio-Technique Co's current Beneish M-Score is -3.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shenzhen Neptunus Interlong Bio-Technique Co stock overvalued right now?
Based on GuruFocus' analysis, Shenzhen Neptunus Interlong Bio-Technique Co (HKSE:08329) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$0.14, compared to a current price of HK$0.10 — trading 29.3% below its estimated fair value. The current Beneish M-Score is -3.57. Shenzhen Neptunus Interlong Bio-Technique Co's overall GF Score™ is 48/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Shenzhen Neptunus Interlong Bio-Technique Co (HKSE:08329), the current Beneish M-Score is -3.57 as of Sep. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shenzhen Neptunus Interlong Bio-Technique Co (HKSE:08329) Overvalued in 2026?

Based on GuruFocus' analysis, Shenzhen Neptunus Interlong Bio-Technique Co stock appears to be undervalued. The current stock price of HK$0.10 is trading 29.3% below its estimated GF Value™ of HK$0.14. GuruFocus considers Shenzhen Neptunus Interlong Bio-Technique Co to be Modestly Undervalued.

Key valuation signals for HKSE:08329:

  • Beneish M-Score: -3.57
  • GF Value™: HK$0.14 vs. price of HK$0.10 (29.3% below fair value)
  • GF Score™: 48/100 with 3 warning signs

No single metric tells the full story. See the HKSE:08329 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shenzhen Neptunus Interlong Bio-Technique Co Business Description

Address 979 King’s Road, 43rd Floor, One Taikoo Place, Quarry Bay, Hong Kong, HKG
Shenzhen Neptunus Interlong Bio-Technique Co Ltd is engaged in the research and development, manufacturing, and selling of medicines and medical devices. It is also involved in the purchase and sale of medicines and healthcare food products. The group's revenue and results from operations are mainly derived from activities in the PRC. The operating segments of the company are the Manufacturing and selling of medicines and medical devices; and the Sales and distribution of medicines, healthcare products, and medical devices.. The majority of revenue is generated from the Manufacturing and selling of medicines and medical devices segment.
48GF Score

Get the complete analysis for HKSE:08329

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.10
Price
HK$0.14
GF Value